These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24657661)

  • 1. Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells.
    Corrado C; Raimondo S; Saieva L; Flugy AM; De Leo G; Alessandro R
    Cancer Lett; 2014 Jun; 348(1-2):71-6. PubMed ID: 24657661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor.
    Corrado C; Saieva L; Raimondo S; Santoro A; De Leo G; Alessandro R
    J Cell Mol Med; 2016 Oct; 20(10):1829-39. PubMed ID: 27196940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
    Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
    J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism.
    Raimondo S; Saieva L; Corrado C; Fontana S; Flugy A; Rizzo A; De Leo G; Alessandro R
    Cell Commun Signal; 2015 Feb; 13():8. PubMed ID: 25644060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320.
    Gao X; Wan Z; Wei M; Dong Y; Zhao Y; Chen X; Li Z; Qin W; Yang G; Liu L
    Theranostics; 2019; 9(19):5642-5656. PubMed ID: 31534508
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis.
    Taverna S; Flugy A; Saieva L; Kohn EC; Santoro A; Meraviglia S; De Leo G; Alessandro R
    Int J Cancer; 2012 May; 130(9):2033-43. PubMed ID: 21630268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between CML cells with HUVECS and BMSCs through CML derived exosomes.
    Cetin Z; Ilker Saygili E; Yilmaz M
    Front Biosci (Landmark Ed); 2021 Jan; 26(3):444-467. PubMed ID: 33049677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia.
    Mukaida N; Tanabe Y; Baba T
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28829353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells.
    Taverna S; Amodeo V; Saieva L; Russo A; Giallombardo M; De Leo G; Alessandro R
    Mol Cancer; 2014 Jul; 13():169. PubMed ID: 25015105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathway.
    Liu Y; Song B; Wei Y; Chen F; Chi Y; Fan H; Liu N; Li Z; Han Z; Ma F
    Cytotherapy; 2018 Feb; 20(2):181-188. PubMed ID: 29269240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K562 cell-derived exosomes suppress the adhesive function of bone marrow mesenchymal stem cells via delivery of miR-711.
    Jiang YH; Liu J; Lin J; Li SQ; Xu YM; Min QH; Zhong QH; Sun F; Li J; You XH; Liao KL; Qin TY; Zhao C; Huang B; Wang XZ
    Biochem Biophys Res Commun; 2020 Jan; 521(3):584-589. PubMed ID: 31677790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death.
    Raimondo S; Naselli F; Fontana S; Monteleone F; Lo Dico A; Saieva L; Zito G; Flugy A; Manno M; Di Bella MA; De Leo G; Alessandro R
    Oncotarget; 2015 Aug; 6(23):19514-27. PubMed ID: 26098775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological and In Vivo Microscopic Analysis of the Bone Marrow Microenvironment in a Murine Model of Chronic Myelogenous Leukemia.
    Weissenberger ES; Krause DS
    Methods Mol Biol; 2016; 1465():59-72. PubMed ID: 27581139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells.
    Askmyr M; Ågerstam H; Lilljebjörn H; Hansen N; Karlsson C; von Palffy S; Landberg N; Högberg C; Lassen C; Rissler M; Richter J; Ehinger M; Järås M; Fioretos T
    Blood Cancer J; 2014 Dec; 4(12):e269. PubMed ID: 25501026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcr-Abl-mediated suppression of normal hematopoiesis in leukemia.
    Lin H; Monaco G; Sun T; Ling X; Stephens C; Xie S; Belmont J; Arlinghaus R
    Oncogene; 2005 May; 24(20):3246-56. PubMed ID: 15735695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia.
    Jin B; Wang C; Li J; Du X; Ding K; Pan J
    Clin Cancer Res; 2017 Feb; 23(3):789-803. PubMed ID: 27492973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CML derived exosomes promote tumor favorable functional performance in T cells.
    Jafarzadeh N; Gholampour MA; Alivand MR; Kavousi S; Arzi L; Rad F; Sadeghizadeh M; Pornour M
    BMC Cancer; 2021 Sep; 21(1):1002. PubMed ID: 34493241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential of Exosomes Derived from Chronic Myelogenous Leukaemia Cells as a Biomarker.
    Kang KW; Jung JH; Hur W; Park J; Shin H; Choi B; Jeong H; Kim DS; Yu ES; Lee SR; Sung HJ; Kim SJ; Choi CW; Kim HK; Hong S; Park JH; Choi Y; Park Y; Kim BS
    Anticancer Res; 2018 Jul; 38(7):3935-3942. PubMed ID: 29970515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 3- receptor targeted exosomes inhibit
    Bellavia D; Raimondo S; Calabrese G; Forte S; Cristaldi M; Patinella A; Memeo L; Manno M; Raccosta S; Diana P; Cirrincione G; Giavaresi G; Monteleone F; Fontana S; De Leo G; Alessandro R
    Theranostics; 2017; 7(5):1333-1345. PubMed ID: 28435469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cells.
    Javidi-Sharifi N; Martinez J; English I; Joshi SK; Scopim-Ribeiro R; Viola SK; Edwards DK; Agarwal A; Lopez C; Jorgens D; Tyner JW; Druker BJ; Traer E
    Elife; 2019 Feb; 8():. PubMed ID: 30720426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.